Skip to main content
Publications
Haug U, Morales DR, Ehrenstein V, Esen BO, Didelez V, Schafer W, Reinbold J, Martinez D Garcia de Albeniz X Target trial emulation with real world evidence: regulatory grade pharmacoepidemiology in the SIGMA consortium
Girardi A, Limoncella G, Hyeraci G, Roberto G, Bartolini C, Paoletti O, Messina D, Villalobos F, Bissacco C, Van den Burg J, Houben E, Santaca k, Lentile V, Ingrasciotta Y, Trifiro G, Hoxhaj V, Duran C, Riera-Arnau J, Garcia P, Martin-Perez M, Huerta-Alvarez C, Llorente-Garcia A, Sanchez-Saez F, Rodriguez-Bernal C, Lassalle R, Jove J, Bernard M, Thurin N, Jordan S, Thayer D, Evans H, Coldea A, Manfrini M, Van Gelder M, Hayati S, Schink T, Tari M, Pajouheshnia R Impact of data source diversity on the distribution of key variables in pregnancy cohorts based on the ConcePTION pregnancy algorithm leveraging a random forest imputation model
Mayer SE, Kawai A Rao S Calingaert B Johannes CB Layton JB Gilsenan A Interim utilization results from a post-approval safety study of Pfizer-BioNTech monovalent COVID-19 vaccine in the United States
Danysh HE Gilsenan A Garcia de Albeniz Martinez X Bartsch J Calingaert B Layton JB Gutierrez L Validation of algorithms to identify breast cancer and bladder cancer among patients with type 2 diabetes mellitus in United States medicare administrative claims
Layton JB Bui CL Anthony MS Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States
Layton JB Bui C Anthony MS Risk of cardiovascular adverse events after COVID-19 diagnosis in the United States
Domenech E, Fortuny J Martinez D Tormos A A post-authorization safety study of golimumab in ulcerative colitis using the Spanish ENEIDA registry (MK8259-042)
Weibel D, De Luise C, Cid Royo A, Ryan O, Vaz T, Aguado J Marsal J Garcia de Albeniz Martinez X Weinrib R Arana A Interim results from the VAC4EU Post-Authorization Safety Study (PASS) among recipients of the Pfizer-BioNTech COVID-19 (Comirnaty®) vaccine in Europe
Ahmadizar F, Fortuny J Plana E Weinrib R Garcia Esteban R Boric K Safety of the Janssen COVID-19 vaccine (JCOVDEN) using VAC4EU European healthcare data sources: methods and results of the second study feasibility assessment
Jacobson MH, Sabido M, Afonso AS, Ajao A, Alghamdi EA, Andrade S, Bennett D, Kharat V, Kurzinger ML, Le Noan-Laine M, Molgaard-Nielsen D, Murray G, Rivero-Ferrer E Algorithms to identify major congenital malformations in routinely collected healthcare databases: a systematic literature review
Peetluk LS, Djibo DA, Layton JB Anthony MS Considerations for negative control outcome analyses in vaccine effectiveness studies: post-hoc analyses from an adult vaccine effectiveness study conducted within the FDA BEST initiative
Broe A, Willis SK, Dareng E, Haviland M, van Gelder MMHJ, Nordeng HME, Wood ME, Sahin L, Margulis AV Rivero-Ferrer E Building global consensus on definitions for drug safety studies in pregnancy to improve harmonized evaluation of real-world data
Layton JB Bui C Kawai AT Anthony MS Events on day zero of follow-up: considerations for cohort studies of adverse events after COVID-19 diagnosis
Layton JB Bui CL Anthony MS Effectiveness over time of a complete primary series of the original, monovalent COVID-19 vaccines among adults aged 18-64 years in the United States
Johannes CB Ziemiecki R Pladevall-Vila M Layton JB Use of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease: a multicountry report from the FOUNTAIN platform
Pajouheshnia R Describing diversity of real-world data sources: a new framework adapted from the DIVERSE initiative scoping review
Weinrib R Fortuny J Martinez D Drug utilisation of radium-223 under routine clinical practice (DIRECT) in Europe: a post-authorisation safety study
Diez-Campelo M, Yucel A, Goyal RK Parikh RC Esterberg E Jimenez M Sluga-O'Callaghan M Treatment characteristics and outcomes in lower-risk, non-del(5q) myelodysplastic syndromes: findings from a medical record review in the USA, Canada and Europe
Gini R, Pajouheshnia R Gutierrez L Arana A Franzoni C Perez-Gutthann S Commentary - Metadata for data dIscoverability aNd study rEplicability in obseRVAtional studies (MINERVA): lessons learnt from the MINERVA project in Europe
Pajouheshnia R Gutierrez L Arana A Franzoni C Perez-Gutthann S Metadata for data dIscoverability aNd study rEplicability in obseRVAtional studies (MINERVA): development and pilot of a metadata list and catalogue in Europe
Romano (DeMuro) C Bratlee-Whhitaker E Herring WL Gnanasakthy K Goss D McLeod L Edwards T Poulos C DiBenedetti D Measuring what matters most to people living with Alzheimer's disease and care partners: what matters most quantitative research development
Cope H, Fischer R, Heslop E, McNiff M, Johnson A, Camino E, Denger B, Armstrong N, Thakrar S, Bateman-House A, Beaverson KL, Woollacott IOC, Phillips D, Fernandez V, Ganot A, Donisa-Dreghici R, Mansfield C Clinician perspectives of gene therapy as a treatment option for Duchenne muscular dystrophy
Clevenger C, Brubaker M, Jackson WC, Stroud J, Peschin S, Fehnel S Brown TM Bratlee-Whitaker E Study protocol: quantitative evaluation of the Agitation in Alzheimer's screener for caregivers (AASC™), a novel tool for improving recognition of agitation in Alzheimer's dementia
Kamudoni P, Amtmann D, Johns J, Cook KF, Salem R, Salek S, Raab J, Middleton R, Repovic P, Alschuler KN, Geldern GV, Wundes A, Barrett A Olayinka-Amao O People with multiple sclerosis help design a tool to measure physical functioning and how it affects their daily lives: a plain language summary
Kessler AS, Brown TM Bratleey-Whitaker E Fehnel S Patient experience with familial chylomicronemia syndrome before and after olezarsen treatment: qualitative interviews with clinical trial participants
